Literature DB >> 10566118

Primary and secondary prevention of atherosclerosis: is there a role for antioxidants?

G Paolisso1, R Esposito, M A D'Alessio, M Barbieri.   

Abstract

Elevated plasma free radical concentration (expression of enhanced oxidative stress) is related to different pathophysiological conditions such as ageing, cancer and diabetes. Nevertheless, even in healthy subjects a rise in plasma free radicals is due to hyperglycaemia, elevated free fatty acids and hyperinsulinaemia. Once elevated oxidative stress occurs, accelerated atherosclerosis may be present. Thus, antioxidants might potentially be useful in preventing or delaying the development of atherosclerosis. Several epidemiological studies have provided conflicting results, whereas interventional studies have demonstrated that antioxidant administration at pharmacological doses is useful for secondary prevention of atherosclerosis. The role of antioxidants in diabetic patients is still debatable, and it is too early to suggest this means for the prevention of atherosclerosis. Concerning trace elements, several studies have indicated that iron, copper, zinc and selenium may play a role in the pathogenesis of atherosclerosis. Nevertheless, only future longitudinal studies can provide a final response. In conclusion, the whole body of studies to date clearly demonstrates that antioxidants may be useful for secondary prevention of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566118

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

1.  Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus.

Authors:  A S Udupa; P S Nahar; S H Shah; M J Kshirsagar; B B Ghongane
Journal:  J Clin Diagn Res       Date:  2012-11

2.  The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people.

Authors:  Robertina Giacconi; Elisa Muti; Marco Malavolta; Catia Cipriano; Laura Costarelli; Gianni Bernardini; Nazzarena Gasparini; Erminia Mariani; Vittorio Saba; Gianfranco Boccoli; Eugenio Mocchegiani
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

Review 3.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Statins in the treatment of polycystic ovary syndrome.

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Semin Reprod Med       Date:  2008-01       Impact factor: 1.303

5.  A comparative study of effects of omega-3 Fatty acids, alpha lipoic Acid and vitamin e in type 2 diabetes mellitus.

Authors:  A Udupa; P Nahar; S Shah; M Kshirsagar; B Ghongane
Journal:  Ann Med Health Sci Res       Date:  2013-07

6.  The Relationship Between Vegetables and Fruits Intake and Glycosylated Hemoglobin Values, Lipids Profiles and Nitrogen Status in Type II Inactive Diabetic Patients.

Authors:  Marjan Tabesh; Mitra Hariri; Gholamreza Askari; Reza Ghiasvand; Maryam Tabesh; Asieh Heydari; Leila Darvishi; Fariba Khorvash
Journal:  Int J Prev Med       Date:  2013-04

7.  Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials.

Authors:  Renfan Xu; Shasha Zhang; Anyu Tao; Guangzhi Chen; Muxun Zhang
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.